RYTM compared with EWTX: revenue, margins and what each company keeps, and the suppliers and customers both name

RYTMRhythm Pharmaceuticals, Inc.

Mkt capRevenueRevenue

EWTXEdgewise Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RYTMRhythm Pharmaceuticals, Inc.

EWTXEdgewise Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

RYTM

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.3%▲+2.92%×0.26

May 5 '26±10.7%▲+7.86%×0.74

Q1 FY26±13.6%▼−1.09%×0.08

Jan 9 '26±5.6%▲+3.65%×0.64

EWTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.6%▼−1.27%×0.11

May 7 '26±8.8%▼−3.81%×0.43

= impliedRYTM realized, solidEWTX realized, hatchedOne scale, both sides: full bar = 27%× = |realized| ÷ impliedSource: market data

Q1 FY26

±13.2%

▼−1.53%

×0.11

Nov 6 '25±27.0%▼−1.61%×0.06

RYTMRhythm Pharmaceuticals, Inc.

94.37· pre 89.25· delayed

Mkt cap$6.4BRevenue$71MQ2 FY26Revenue$190MFY25

EWTXEdgewise Therapeutics, Inc.

38.13· pre 38.14· delayed

Pre-marketNov 3 '26delayed

Mkt cap$4.2BRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

RYTMRhythm Pharmaceuticals, Inc.

EWTXEdgewise Therapeutics, Inc.

94.37pre 89.25delayed

Price

38.13pre 38.14delayed

$6.4B

Mkt cap

$4.2B

Q2 FY26$71M

Revenue

—

FY25$190M

Revenue

—

RYTM94.37vsEWTX38.13Pre-marketNov 3 '26delayed